My name’s Iain Frame I’m the Chief Executive Officer of NCRI. The conference so far has been the opening plenary session. I thought the quality of the speakers was excellent and we went from one great topic to another and ending with Richard Gilbertson’s tour de force on brain cancer. It was a superb start to the conference. The thing that I’m most excited about in 2019 for cancer research is watching some of the great results coming through from basic research and seeing them translated for patient benefit. I think the time is right for a lot of that sort of research to come good.